Victory Capital Management Inc Centogene N.V. Transaction History

Victory Capital Management Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 03, 2021	SELL	$9.02 - $12.93 $607,677 - $871,094	-67,370 Closed	0 $0
Q1 2021 May 04, 2021	SELL	$10.56 - $13.94 $13,200 - $17,425	-1,250 Reduced 1.82%	67,370 $817,000
Q4 2020 Feb 01, 2021	SELL	$9.44 - $13.3 $39,553 - $55,727	-4,190 Reduced 5.75%	68,620 $740,000
Q3 2020 Nov 09, 2020	BUY	$9.3 - $25.16 $209,250 - $566,100	22,500 Added 44.72%	72,810 $689,000
Q2 2020 Aug 07, 2020	SELL	$15.99 - $22.88 $3.58 Million - $5.12 Million	-223,718 Reduced 81.64%	50,310 $1.15 Million

Q1 2020 May 04, 2020	SELL	$9.76 - $23.8 $186,142 - $453,913	-19,072 Reduced 6.51%	274,028 $5.48 Million
Q4 2019 Feb 04, 2020	BUY	$8.1 - $14.6 $2.37 Million - $4.28 Million	293,100 New	293,100 $2.86 Million

2.14M

Ticker CNTG
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 27,081,600
Market Cap $10.3M
Description
Centogene N.V., together with its subsidiaries, focuses on rare diseases that transforms real-world clinical and genetic, or other data into actionable information for patients, physicians, and pharmaceutical companies worldwide. It operates through three segments: Pharmaceutical, Diagnostics, and COVID-19 testing. The company develops rare dise...

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

Stay updated on Victory Capital Management Inc with notifications on news.